Maternal infections during pregnancy increase the risk for schizophrenia and related disorders of putative neurodevelopmental origin in the offspring. This association has been attributed to enhanced expression of pro-inflammatory cytokines in the fetal environment in response to maternal immunological stimulation. In contrast, the specific roles of anti-inflammatory cytokines are virtually unknown in this context. Here, we demonstrate that genetically enforced expression of the anti-inflammatory cytokine interleukin (IL)-10 by macrophages attenuates the long-term behavioral and pharmacological consequences of prenatal immune activation in a mouse model of prenatal viral-like infection by polyriboinosinic-polyribocytidilic acid (PolyI:C; 2 mg/kg, intravenously). In the absence of a discrete prenatal inflammatory stimulus, however, enhanced levels of IL-10 at the maternal-fetal interface by itself also precipitates specific behavioral abnormalities in the grown offspring. This highlights that in addition to the disruptive effects of excess pro-inflammatory molecules, a shift toward enhanced antiinflammatory signaling in prenatal life can similarly affect cognitive and behavioral development. Hence, shifts of the balance between pro-and anti-inflammatory cytokine classes may be a critical determinant of the final impact on neurodevelopment following early life infection or innate immune imbalances.
Introduction
Fetal brain development is particularly vulnerable to environmental insults, and deviations from the normal course of brain development are assumed to underlie several mental disorders, including schizophrenia 1, 2 and autism. 3 Epidemiological studies have indicated that maternal infections during pregnancy increase the risk for these disorders in the offspring. [4] [5] [6] [7] According to one hypothesis, the maternal cytokine response to infections may play a crucial role in this association, 8 because the induction of cytokines is a fundamental immunological event triggered by virtually any infection. 9 More specifically, it has been suggested that activation of pro-inflammatory cytokines, including interleukin (IL)-1b, IL-6 and tumor necrosis factor (TNF)-a, mediate the neurodevelopmental effects of maternal infections on the offspring. This class of cytokines can modulate neuronal differentiation, 10 survival 11 and dendrite growth and complexity in vitro. 12 They may also be critically involved in the precipitation of the long-term behavioral, cognitive and pharmacological consequences of prenatal immune challenge as shown in vivo. [13] [14] [15] [16] [17] [18] [19] [20] In contrast, very little is known about the putative roles of anti-inflammatory cytokines in the association between prenatal inflammation and the emergence of brain and behavioral abnormalities. One of the best characterized anti-inflammatory cytokine is IL-10. By antagonizing the biological activities and/or production of multiple pro-inflammatory molecules, it crucially regulates inflammation in both acute and chronic conditions. 21, 22 Enhanced expression of IL-10 at the maternal-fetal interface may thus readily attenuate the long-lasting effects of prenatal exposure to pro-inflammatory cytokines. However, evidence for this hypothesis is still lacking, and the ability of IL-10 to modulate brain and behavioral development remains to be elucidated.
The present study addressed these issues by comparing the pathological consequences of prenatal exposure to pro-inflammatory cytokines in wild-type (wt) and transgenic mice constitutively overexpressing IL-10 in macrophages (macIL-10tg). This genetic manipulation leads to the autocrine deactivation of macrophages, which is accompanied by attenuated pro-inflammatory cytokine reactions to acute immunological stimulation by the bacterial endotoxin lipopolysaccharide (LPS). 23 The restriction of IL-10 overexpression to macrophages allows us to specifically assess the impact of peripheral maternal IL-10 on the susceptibility to prenatal inflammationmediated behavioral and pharmacological dysfunctions in the grown offspring. This specificity is also in keeping with the hypothesis that maternal immunological factors transmitted to the offspring in utero may represent the critical link between prenatal infections and the emergence of brain and behavioral dysfunction later in life. 24, 25 Here, we studied the effects of macrophage-specific IL-10 overexpression in a recently established animal model of prenatal exposure to polyriboinosinic-polyribocytidilic acid (PolyI:C) in mice. PolyI:C is a synthetic analogue of double-stranded RNA that leads to a pronounced but time-limited production of pro-inflammatory cytokines after administration to mammalian organisms. 26, 27 Maternal immune activation by PolyI:C exposure in rodents is known to precipitate a wide spectrum of behavioral, cognitive and pharmacological abnormalities in the adult offspring. [14] [15] [16] [17] [18] [19] Hence, the combination of the prenatal PolyI:C model with a mouse model of genetically driven IL-10 overexpression by macrophages allows us to explore the effects of pro-and anti-inflammatory cytokine signaling on brain and behavioral development following prenatal inflammatory conditions and innate immune imbalances. Here, we focused on the impact of the genetically and environmentally induced immunological manipulations on behavioral functions and pharmacological responses known to be disrupted by prenatal immune challenge, including sensorimotor gating, selective associative learning, spontaneous exploratory behavior and sensitivity to the psychomotor-stimulant effects of dopaminergic and glutamatergic drug challenge. [14] [15] [16] [17] [18] [19] 
Methods

Animals
The generation of macIL-10tg FVB mice expressing an epitope-tagged IL-10 (Flag-IL-10) under control of the human CD68 promoter has been fully described elsewhere. 23 Transgene-bearing hemizygous male mice were mated with wt FVB females obtained from Jackson Laboratory (Bar Harbor, ME, USA). The resulting F1 hemizygous transgene-positive (macIL-10tg) female and male offspring were kept as transgene breeding pairs; and the resulting F1 transgene-negative control littermates (wt) were kept as wt breeders. F1 breeding pairs were maintained for the timed mating procedure as described below. All animals were kept in a temperature-and humiditycontrolled (21711C, 5575%) holding facility under a reversed light-dark cycle (lights off: 0800-2000 hours) and had ad libitum access to food (Kliba 3430, Klibamü hlen, Kaiseraugst, Switzerland) and water. All procedures described in the present study had been approved previously by the Zurich Cantonal Veterinary Office and are in agreement with the Principles of Laboratory Animal Care (National Institutes of Health publication no. 86-23, revised 1985).
Timed mating procedure and prenatal treatment For the purpose of the prenatal manipulations in mid-pregnancy, F1 macIL-10tg and wt breeders were subjected to a timed mating procedure as fully described before. 16 Pregnant dams on gestation day (GD) 9 received either a single injection of PolyI:C or vehicle solution via the intravenous route at the tail vein under mild physical constraint. PolyI:C (potassium salt) was obtained from Sigma-Aldrich (Buchs, St Gallen, Switzerland) and dissolved in isotonic 0.9% NaCl solution to obtain the desired dosage (2 mg/kg, calculated based on the pure form PolyI:C). The volume of injection was 5 ml/kg. F1 macIL-10tg breeding resulted in F2 macIL-10tg offspring either bearing one or two copies of the Flag-IL-10 transgene and F1 wt breeding yielded F2 wt offspring.
Behavioral assays
Offspring born to PolyI:C-or vehicle-treated F1 macIL-10tg and wt mothers were weaned and sexed at postnatal day 21. Littermates of the same sex were caged separately and maintained as described above. Behavioral testing started at 14-16 weeks of age, and included both male and female offspring.
Open field exploration. Spatial exploration was assessed in four identical square arenas (40 Â 40 Â 35 cm high) made of wood and painted black as fully described elsewhere. 16 For the purpose of data collection, the arenas were conceptually partitioned into two zones: a center zone in the middle of the arena (measuring 13.5 Â 13.5 cm 2 ) and a peripheral zone occupying the remaining area. The dependent measures were (i) distance moved in the entire open field arena and (ii) time spent in the central area of the open field. These measures were analyzed as a function of 5-min bins with the between-subjects factors of genotype, prenatal treatment and sex.
Prepulse inhibition. The prepulse inhibition (PPI) test was conducted by using four startle chambers for mice (San Diego Instruments, San Diego, CA, USA), in which the startle reflex was induced by a 120-dB [A] white noise pulse stimulus. The test apparatus and procedure have been fully described elsewhere. 16 Inhibition of the pulse-elicited startle reflex was achieved by using a 20-ms white noise prepulse of five different intensities (69, 73, 77, 81 and 85 dB[A]). PPI was indexed by percent inhibition of the startle response obtained in the pulse-alone trials by the following expression: 100% Â [1À(mean reactivity on prepulse þ pulse trials/mean reactivity on pulse-alone trials)] for each subject, and at each of the five possible prepulse intensities. Percent PPI was analyzed as a function of prepulse intensities with the between-subjects factors of genotype, prenatal treatment and sex. In addition, the startle reactivity to prepulse-alone trials, and to pulse-alone and prepulse þ pulse trials was subjected to statistical analysis.
Latent inhibition. Latent inhibition (LI) was assessed in a two-way active avoidance procedure using four identical two-way shuttle boxes (model H10-11M-SC; Coulbourn Instruments, Allentown, PA, USA) as fully described before. 18 The test procedures consisted of two phases: pre-exposure (PE) and conditioning, conducted 24 h apart. Animals from each of the four treatment groups were allocated to one of the two conditions: conditioned stimulus (CS)-PE and non-pre-exposure (NPE).
In the PE phase, the PE subjects were placed in the appropriate test chambers and presented with 100 PEs to a 5-s noise CS according to a random interstimulus interval schedule of 40715 s. The NPE subjects were confined to the chamber for an equivalent period of time without any stimulus presentation. The total number of shuttle responses performed during the PE session was recorded.
On conditioning day, the subjects were returned to the same shuttle boxes and received a total of 100 avoidance trials presented with an intertrial interval of 40715 s. A trial began with the onset of the noise CS. If the animal shuttled within 5 s of CS onset, the CS was terminated and the animal avoided the electric shock on that trial. Avoidance failure led immediately to an electric foot shock presented in coincidence to the CS. This could last for a maximum of 2 s but could be terminated by a shuttle response during this period (that is, an escape response).
To index conditioned avoidance learning, the mean number of avoidance shuttles performed on successive 10-trial blocks were analyzed with the betweensubjects factors of PE, genotype, prenatal treatment and sex. To account for general locomotor activity, the spontaneous shuttles performed during the interstimulus intervals were also subjected to statistical analysis.
Drug-induced locomotor activity. The tests for druginduced locomotor activity were conducted in an open field apparatus as described above. First, the animals were injected with vehicle (isotonic 0.9% NaCl solution) solution and immediately placed in the apparatus. Locomotor activity was then measured for 30 min as described above. Subsequently, the animals were removed from the apparatus and administered with either d-amphetamine sulfate (AMPH, 2.5 mg/kg, intraperitoneally) or dizocilpine (MK-801; 0.1 mg/kg, intraperitoneally). They were then immediately returned to the same arena again, and the locomotor response to the acute drug challenge was monitored for a period of 60 min. The distance traversed in the entire open field arena was expressed as a function of 5-min bins and analyzed with the between-subjects factors of genotype, prenatal treatment and sex. The data collected on the two phases of the experiments (that is, vehicle treatment and drug treatment) were analyzed separately.
Blood sampling
Non-pregnant macIL-10tg and wt adult female mice were either subjected to vehicle (isotonic 0.9% NaCl) or PolyI:C treatment as described above. Blood was taken from the orbital sinus under methoxyflurane (2,2-dichloro-1,1-difloroethymethyl ether; PitmanMoore, Washington, NJ, USA) anesthesia 30 min after vehicle treatment, or 1.5 and 5 h after systemic PolyI:C treatment, respectively. The collected blood was allowed to clot at room temperature for 1 h before centrifugation at 12 000 r.p.m. for 20 min at 41C. The resulting serum from each animal was subdivided to permit storage (À801C) until the cytokine assay was performed (see below).
Collection of fetal and adult brain tissue samples
For the purpose of assessing the acute effects of maternal PolyI:C administration on the cytokine protein levels in fetal brain tissue, pregnant macIL10tg and wt dams on GD 9 were either exposed to PolyI:C or vehicle treatment, as described above, and killed by cervical dislocation 5 h post-treatment. Fetal brains were extracted under visual guidance using a dissecting microscope (Stemi 2000-C; Zeiss, Oberkochen, Germany), as described previously. 16, 17 Each fetal brain sample was weighed, placed in 1-ml Eppendorf (Hamburg, Germany) tubes, and stored at À801C until further processing (see below). To assess the long-term cytokine effects of prenatal PolyI:C exposure, pregnant macIL-10tg and wt dams were administered with PolyI:C or vehicle on GD 9 as described above, and the animals were allowed to give birth. The resulting offspring were killed by decapitation when they reached 100 days of age. The brains were extracted from the skull and placed ventral side up in a mouse brain matrix (RBM-200c; ASI Instruments, Warren, MI, USA) on an ice-chilled plate. Double-edged ice-cooled blades were used to prepare 2-mm-thick coronal sections. The resulting slices were placed on an ice-cold dissection plate for the removal of discrete brain regions, using a 1-mm micropunch for the medial prefrontal cortex, caudate putamen, dorsal hippocampus and ventral hippo-campus. Punch tips were inserted into the brain region of interest and then withdrawn. Tissue punches from the left and right hemispheres of each area were weighed, placed in 1-ml Eppendorf tubes and stored at À801C until further processing (see below).
Cytokine protein assays
Before conducting the cytokine protein assays, fetal and adult brain samples were placed in 150 ml Tris-HCl buffer (50 mM, pH 7.4) with NaCl (0.6 M), Triton X-100 (0.2%) and bovine serum albumin (0.5%) containing freshly dissolved protease inhibitors: benzamidine (1 mM), benzethonium chloride (0.1 mM) and phenylmethylsulfonyl fluoride (0.1 mM). Samples were homogenized (TissueTearor; BioSpec Products, Bartlesville, OK, USA) for 10 s, sonicated (Vibra Cell; Sonics & Materials, Newtown, CT, USA) for 20 s at 10 mV and centrifuged at 12 000 r.p.m. for 20 min at 41C. The supernatants were aliquoted and frozen at -801C until the cytokine assays were performed.
Serum and brain cytokine protein contents were measured using a multiplexed particle-based flow cytometric cytokine assay. Fluorokine MAP (multianalyte profiling) mouse kits for IL-1b, -6, -10 and TNF-a were purchased from R&D Systems (Wiesbaden-Nordenstadt, Germany). The procedures closely followed the manufacturer's instructions. The analysis was conducted using a conventional flow cytometer (LSR II; BD Biosciences, San Jose, CA, USA). The detection limits were 2.1 for IL-1b, 0.2 for IL-6, 0.8 for IL-10 and 0.4 pg/ml for TNF-a.
Genotyping
Standard PCR procedures were used to verify the animals' genotype using genomic DNA isolated from tail tips. The following primers were used: Flag-IL-10 (sense:
. PCR cycles started with denaturation of DNA at 951C for 10 min followed by 35 cycles of the following three conditions: 951C, 30 s; 591C, 1 min; 721C, 1 min, followed by a final extension at 721C for 5 min.
Statistical analysis
All data (except serum cytokine measures) were analyzed using parametric analysis of variance, followed by Fisher's least significant difference post hoc comparisons whenever appropriate. Serum cytokine contents were separately analyzed using independent Student's t-tests. Statistical significance was set at P < 0.05 (two-tailed). Analyses were conducted using the statistical software StatView (version 5.0) implemented on a personal computer running the Windows XP operating system.
Results
Cytokine responses to PolyI:C-induced immune stimulation in macIL-10tg and wt mice First, we assessed the efficacy of systemic PolyI:C exposure (2 mg/kg, intravenously) to induce cytokine responses in non-pregnant female mice constitutively overexpressing IL-10 in macrophages (macIL-10tg mice), in comparison to wt controls. MacIL-10tg animals have previously been shown to display a markedly attenuated pro-inflammatory cytokine response to immunological stimulation by the bacterial endotoxin LPS. 23 Consistent with previous results, 23 macIL-10tg animals displayed higher IL-10 levels in basal conditions compared to wt controls, as indicated by the 50-fold elevation of serum IL-10 in macIL-10tg relative to wt mice following the administration of vehicle (saline) solution ( Figure 1a ). The serum IL-10 response to the PolyI:C-induced immune challenge was also greatly increased in macIL-10tg mice compared to wt controls at both sampling times (that is, at 1.5 and 5 h post-treatment; Figures 1b and c). Moreover, while macIL-10tg and wt mice did not differ significantly in basal serum levels of IL-6 and TNF-a, macIL-10tg animals displayed significantly reduced IL-6 and TNF-a responses to systemic PolyI:C treatment in comparison with wt mice. These effects of the transgene were largely independent of sampling times (Figures 1b and c) .
Macrophage-specific overexpression of IL-10 modulates fetal brain cytokine contents in prenatal inflammatory and non-inflammatory conditions Next, we evaluated whether macrophage-specific IL-10 overexpression would also modulate pro-and anti-inflammatory cytokine contents in the fetal brain during maternal inflammatory and non-inflammatory conditions. Therefore, we assessed the effects of maternal PolyI:C exposure, relative to vehicle (saline) treatment, on fetal brain contents of IL-1b, -6, -10 and TNF-a in macIL-10tg and wt animals.
Consistent with our previous report, 17 maternal exposure to PolyI:C markedly increased fetal brain contents of both IL-1b and IL-6 relative to vehicle treatment. This effect emerged largely independently of the genetic background of the animals ( Figure 2 ). Fetal brain levels of IL-1b and IL-6 also did not differ significantly between macIL-10tg and wt mice after maternal vehicle treatment ( Figure 2 ). Most interestingly, however, maternal PolyI:C exposure increased fetal brain TNF-a contents only in wt, but not macIL10tg animals. Indeed, fetal brain contents of TNF-a in macIL-10tg animals were not responsive to the maternal PolyI:C treatment and remained at basal levels ( Figure 2 ). On the other hand, fetal brain levels of IL-10 were substantially enhanced in immunechallenged as well as non-challenged macIL-10tg animals relative to vehicle-and PolyI:C-exposed wt offspring ( Figure 2 ). This confirms that fetal brain levels of IL-10 were entirely determined by the genetic background, rather than the maternal immunological treatment.
Fetal brain ratios of IL-1b/IL-10, IL-6/IL-10 and TNF-a/IL-10 were then analyzed to determine the relative pro-versus anti-inflammatory cytokine responses to maternal PolyI:C or vehicle treatment.
In comparison to prenatal vehicle administration in wt mice, maternal exposure to PolyI:C significantly increased the ratios of IL-1b/IL-10, IL-6/IL-10 and TNF-a/IL-10 in the brains of wt fetuses (Figure 3 ). This demonstrates a pronounced shift toward proinflammatory cytokine species after prenatal immune Figure 1 Macrophage-specific overexpression of IL-10 increases peripheral IL-10 levels in basal and inflammatory conditions and attenuates pro-inflammatory cytokine responses to immunological stimulation. (a) Adult mice constitutively overexpressing IL-10 by macrophages (macIL-10tg) displayed a 50-fold increase in basal serum IL-10 contents compared to wild-type littermates (wt). On the other hand, the genetic manipulation did not significantly alter serum levels of IL-1b, IL-6 or TNF-a in response to vehicle (saline) treatment. MacIL-10tg mice exhibited attenuated IL-6 and TNF-a responses to systemic PolyI:C (2 mg/kg, intravenously) relative to wt animals 1.5 h (b) and 5 h (c) post-treatment. This effect was paralleled by a markedly enhanced IL-10 response in macIL-10tg mice relative to wt subjects at both sampling times. In contrast, the macrophage-specific overexpression of IL-10 did not significantly alter the IL-1b response to PolyI:C treatment at either sampling time. N = 5 in all groups and for all treatment conditions/sampling times. All values are means7s.e.m. Symbols (*), (**) and (***) refer to a statistically significant difference of P < 0.05, P < 0.01 and P < 0.001, respectively, between macIL-10tg and wt mice based on independent Student's t-tests (two-tailed). IL-10, interleukin-10; PolyI:C, polyriboinosinicpolyribocytidilic acid; tg, transgenic; TNF-a, tumor necrosis factor-a; wt, wild type. Figure 2 Macrophage-specific overexpression of IL-10 modulates fetal brain cytokine contents in basal and inflammatory conditions. In comparison to prenatal vehicle (saline) treatment, maternal PolyI:C exposure was only effective in increasing fetal brain TNF-a contents in wt, but not macIL-10tg mice. This led to a significant genotype Â maternal treatment interaction (F (1,76) = 6.11; P < 0.05) in the ANOVA of fetal brain TNF-a contents. Subsequent Fisher's LSD post hoc comparison between the four groups verified a significant elevation of fetal brain TNF-a contents in PolyI:C-exposed wt mice relative to all other groups (**P < 0.01). On the other hand, maternal exposure to PolyI:C increased fetal brain protein levels of IL-1b and -6 independent of the genetic background in comparison with maternal vehicle treatment. ANOVA of fetal brain IL-1b and -6 contents only yielded significant main effects of maternal treatment (IL-1b: F (1,76) = 15.22; ***P < 0.001; IL-6: F (1,76) = 14.98; ***P < 0.001). Fetal brain IL-10 contents were exclusively modulated by the macrophage-specific overexpression of IL-10, leading to similarly enhanced fetal brain IL-10 levels in both immune-challenged and non-challenged macIL-10tg offspring relative to wt offspring. ANOVA of fetal brain IL-10 contents revealed a highly significant main effect of genotype (F (1,76) = 16.56; ***P < 0.001). N(fetuses) = 20 in each group; fetuses were derived from four mothers in every experimental conditions. All values are means7s.e.m. ANOVA, analysis of variance; IL-10, interleukin-10; LSD, least significant difference; PolyI:C, polyriboinosinic-polyribocytidilic acid; tg, transgenic; TNF-a, tumor necrosis factor-a; wt, wild type. challenge in wt fetuses. In contrast, prenatal PolyI:C treatment in macIL-10tg mice was not efficient in increasing any of these ratios in the fetal brains. Indeed, fetal brain ratios of IL-1b/IL-10 and IL-6/IL-10 were virtually identical in PolyI:C-exposed macIL10tg and vehicle-exposed wt mice; and the ratio of TNF-a/IL-10 was significantly decreased in PolyI: C-exposed macIL-10tg fetuses relative to prenatal vehicle treatment in wt mice (Figure 3) . Importantly, ratios of IL-1b/IL-10, IL-6/IL-10 and TNF-a/IL-10 were significantly decreased in the brains of fetuses derived from vehicle-treated macIL-10tg mothers in comparison with vehicle treatment in wt mice ( Figure  3) , indicating a shift toward attenuated pro-inflammatory cytokine signaling in vehicle-exposed macIL-10tg offspring. Hence, macrophage-specific overexpression of IL-10 modulates the fetal brain balances between pro-and anti-inflammatory cytokines in prenatal inflammatory and non-inflammatory conditions.
Prenatal immune challenge and macrophage-specific overexpression of IL-10 do not lead to cytokine changes in the adult brain To rule out the possibility that the prenatal immune challenge in macIL-10tg and wt animals may be additionally linked to persistent cytokine alterations in the adult brain, we also analyzed the protein contents of IL-1b, IL-6, IL-10 and TNF-a in adult brain tissue. This analysis yielded no evidence for longlasting alterations in adult brain cytokine contents as a result of prenatal inflammation (Table 1) . Similarly, the constitutive overexpression of IL-10 by peripheral macrophages did not significantly alter any of the cytokines measured in the adult brain (Table 1) . Maternal immunological stimulation and/or macrophage-specific overexpression of IL-10 thus only modulated cytokine contents in the fetal, but not adult brain. Figure 3 Macrophage-specific overexpression of IL-10 modulates the fetal brain balances between pro-and antiinflammatory cytokines in prenatal inflammatory and basal conditions. Maternal PolyI:C exposure in wt mice significantly increased the fetal brain ratios of IL-1b/IL-10, IL-6/IL-10 and TNF-a/IL-10 relative to prenatal vehicle treatment in wt animals. In contrast, prenatal PolyI:C exposure in macIL10tg mice was inefficient in increasing any of these ratios in the fetal brains. Fetal brain ratios of IL-1b/IL-10 and IL-6/IL-10 in PolyI:C-treated macIL-10tg offspring were similar to those found in vehicle-exposed wt mice; and the ratio of TNF-a/IL-10 was significantly decreased in PolyI:C-exposed macIL-10tg fetuses relative to prenatal vehicle treatment in wt mice. In the absence of a discrete inflammatory stimulus, macrophage-specific overexpression led to significant decreases in the fetal brain ratios of IL-1b/IL-10, IL-6/IL-10 and TNF-a/IL-10 relative to vehicle treatment in wt animals. Symbols (*), (**) and (***) refer to statistically significant differences at P < 0.05, P < 0.01 and P < 0.001, respectively, based on Fisher's LSD post hoc comparisons following significant main effects of treatment in one-way ANOVAs conducted for each of the three ratios (TNF-a/IL-10: F (3,61) = 15.13, P < 0.001; IL-1b/IL-10: F (3,61) = 9.90, P < 0.001; IL-6/IL-10: F (3,61) = 10.98, P < 0.001). Dashed lines indicate the control ratio levels in fetuses derived from vehicletreated wt mothers. N(fetuses) = 20 in each group; fetuses were derived from four mothers in every experimental conditions. All values are means7s.e.m. ANOVA, analysis of variance; IL-10, interleukin-10; LSD, least significant difference; PolyI:C, polyriboinosinic-polyribocytidilic acid; tg, transgenic; TNF-a, tumor necrosis factor-a; wt, wild type. Abbreviations: IL-10, interleukin-10; mPFC, medial prefrontal cortex; CPu, caudate putamen; dHIP, dorsal hippocampus; PolyI:C, polyriboinosinic-polyribocytidilic acid; tg, transgenic; vHIP, ventral hippocampus; wt, wild type. Maternal PolyI:C exposure in mid-pregnancy did not lead to significant long-term alterations in the offspring's basal brain levels of IL-1b or -10. Similarly, adult brain cytokine contents were not significantly affected by the macrophage-specific overexpression of IL-10. Adult brain levels of IL-6 and TNF-a were below detection limits. N = 10 (5#, 5~) in every experimental group. All values are means7s.e.m.
Maternal IL-10 modulates behavioral dysfunctions emerging in adult offspring after prenatal immune challenge Next, we explored whether differential maternal IL-10 levels during pregnancy may modulate the offspring's vulnerability to prenatal inflammation-mediated behavioral dysfunctions emerging in adult life. Pregnant macIL-10tg and wt mice received either a single injection of PolyI:C (2 mg/kg, intravenously) or vehicle solution on GD 9, and the resulting offspring were then compared in a number of behavioral paradigms when they reached 14-16 weeks of age. Here, we focused on adult spatial exploration, sensorimotor gating and selective associative learning, because previous reports in rodents have repeatedly demonstrated that prenatal PolyI:C exposure leads to functional abnormalities in these neuropsychological domains when the animals reach adult age. [14] [15] [16] [17] [18] [19] First, spatial exploration was studied in an open field by focusing on the time the animals spent in the central area of the field during a 30-min test period. This test is widely applied to assess explorative behavior in rodents. 28 Consistent with our previous findings, 16, 17 offspring of PolyI:C-treated wt mothers showed a marked reduction in this measure compared to animals born to vehicle-treated wt mothers (Figure 4a ). Most importantly, this effect of prenatal PolyI:C exposure was attenuated in macIL-10tg offspring, as offspring of PolyI:C-treated macIL-10tg mothers did not significantly differ from offspring born to vehicle-treated wt mice. However, a significant suppression in open field exploration was noted in adult offspring of vehicle-treated macIL-10tg mothers (Figure 4a ). The total distance traveled in the open field did not differ significantly between the prenatal treatment conditions or between genotypes (Figure 4b) . Hence, the suppression of spatial exploration could not be attributed to changes in overall locomotor activity.
We next assessed sensorimotor gating using the paradigm of PPI of the acoustic startle reflex. PPI deficiency has been linked to several neuropsychiatric disorders with a presumed neurodevelopmental origin, including schizophrenia 29 and autism. 30 Consistent with previous reports, 14, 16, 19 prenatal PolyI:C exposure impaired PPI (indexed as percent inhibition) in adult wt offspring compared to prenatal vehicle treatment in wt animals (Figure 5a ). Most importantly, the PPI disrupting effect of prenatal PolyI:C exposure was completely absent in mice with the macrophage-specific overexpression of IL-10 ( Figure 5a ). Exposure to prenatal PolyI:C administration also enhanced the startle reaction to pulse-alone trials (Figure 5b ). Since this effect emerged independently of genotype, the PPI attenuating effects of prenatal PolyI:C exposure in wt mice cannot be solely accounted by its effects on general startle reactivity, 31, 32 and it probably reflects a genuine deficiency in sensorimotor gating.
Next, we compared the efficacy of prenatal PolyI:C exposure to affect the LI effect, which is a form of selective associative learning reported to be impaired in acutely schizophrenic patients, 33, 34 in macIL-10tg and wt animals using a two-way active avoidance procedure. The LI effect is demonstrated when conditioned avoidance learning is impeded in animals pre-exposed to the to-be-CS relative to non-preexposed subjects. Significant LI was obtained in adult (a) Adult mice born to PolyI:C-exposed wt mothers showed a significant deficit in exploratory behavior compared with prenatally vehicle-treated wt mice, as evident by the reduction in the time spent in the central area of the open field. These effects were reversed in macIL-10tg mice, that is suppressed spatial exploration emerged in offspring of vehicle-treated macIL-10tg mice, but not in adult animals born to PolyI:C-treated macIL-10tg mothers. ANOVA of time spent in the central area of the open field yielded a significant genotype Â prenatal treatment interaction (F (1,56) = 6.78; P < 0.05). Subsequent Fisher's LSD post hoc comparisons confirmed that offspring of PolyI:C-treated wt mothers (*P < 0.05) and offspring of vehicle-treated macIL-10tg mothers (*P < 0.05) displayed an overall reduction in this measure compared to prenatally vehicle-treated wt mice. (b) No group difference in basal locomotor activity expressed as distance moved in the whole arena was revealed. Hence, the suppression of exploratory behavior in wt-PolyI:C and macIL-10tg-vehicle offspring cannot be attributed to any changes in general locomotor activity. N = 16 (8#, 8~) in each of the four groups. All values are means7s.e.m. ANOVA, analysis of variance; IL-10, interleukin-10; LSD, least significant difference; PolyI:C, polyriboinosinic-polyribocytidilic acid; tg, transgenic; wt, wild type. Figure 5 Macrophage-specific overexpression of IL-10 attenuates the emergence of prepulse inhibition (PPI) deficiency after prenatal immune challenge. (a) PPI was indexed by percent inhibition, defined as the percent reduction in reactivity in prepulse þ pulse trials relative to pulse-alone trials. Increasing prepulse intensity led to increased magnitude of PPI. Prenatal PolyI:C exposure reduced PPI in wt, but not in macIL-10tg offspring relative to prenatal vehicle treatment. ANOVA of percent PPI yielded a genotype Â prenatal treatment interaction (F (1,56) = 5.21; P < 0.05), and subsequent Fisher's LSD post hoc comparisons verified a significant difference between adult offspring born to PolyI:C-and vehicle-treated wt mothers (*P < 0.05). (b) Maternal PolyI:C exposure also enhanced the offspring's startle reactivity to pulse-alone trials, and this effect emerged independently of the genetic background of the animals. This led to a significant main effect of prenatal treatment (F (1,56) = 5.71; *P < 0.05) in the ANOVA of startle reaction to pulse-alone trials. No significant group differences were detected in the offspring's reaction to prepulse-alone trials (data not shown). N = 16 (8#, 8~) in each experimental group. All values are means7s.e.m. ANOVA, analysis of variance; IL-10, interleukin-10; LSD, least significant difference; PolyI:C, polyriboinosinic-polyribocytidilic acid; tg, transgenic; wt, wild type. Figure 6 Macrophage-specific overexpression of IL-10 prevents prenatal inflammation-induced latent inhibition (LI) deficiency but leads to a loss of LI in the absence of prenatal immunological stimulation. A two-way active avoidance procedure was used to study LI. A clear LI effect (that is, reduced avoidance learning in CS-pre-exposed (PE) subjects relative to non-pre-exposed (NPE) subjects) was observed in adult offspring of vehicle-treated wt mothers as well as in animals born to PolyI:C-treated macIL-10tg mothers. In contrast, LI was absent in offspring of PolyI:C-treated wt mice, which was attributable to enhanced avoidance learning in the PE subjects together with reduced avoidance learning in the NPE subjects, in comparison to the PE and NPE subjects in the vehicle-treated wt group. A loss of LI was also noted in prenatally vehicletreated macIL-10tg animals relative to vehicle-treated wt subjects, but this was entirely attributable to impaired conditioning in NPE subjects relative to the NPE subjects in the vehicle-treated wt group. ANOVA of the mean number of avoidance shuttles performed on successive 10-trial blocks of CS-US parings yielded a significant genotype Â prenatal treatment Â PE interaction (F (1,71) = 5.58; P < 0.05). Additional ANOVAs of this measure restricted to each of the four experimental groups further verified the presence of a CS-PE effect in offspring of vehicle-treated wt mothers (F (1, 19) = 37.24; **P < 0.001) and offspring of PolyI:C-treated macIL-10tg mothers (F (1,18) = 4.28; *P < 0.05), but not in the other two experimental groups. N(vehicle wt/NPE) = 11 (6#, 5~); N(vehicle wt/PE) = 10 (5#, 5~); N(PolyI:C wt/NPE) = 9 (5#, 4~); N(PolyI:C wt/PE) = 9 (5#, 4~); N(vehicle IL-10tg/NPE) = 10 (5#, 5~); N(vehicle IL-10tg/PE) = 10 (5#, 5~); N(PolyI:C IL-10tg/NPE) = 9 (5#, 4~); N(PolyI:C IL-10tg/PE) = 11 (6#, 5~). All values are means7s.e.m. ANOVA, analysis of variance; CS-US, conditioned stimulus-unconditioned stimulus; IL-10, interleukin-10; LSD, least significant difference; PolyI:C, polyriboinosinicpolyribocytidilic acid; tg, transgenic; wt, wild type. animals born to vehicle-treated wt mothers, as well as in offspring of PolyI:C-treated macIL-10tg mothers ( Figure 6 ). On the other hand, LI was completely absent in wt PolyI:C and macIL-10tg vehicle offspring ( Figure 6 ). In agreement with the results obtained in the open-field test (Figure 4b ), spontaneous locomotor activity did not differ between genotypes, prenatal treatment or between PE conditions, because no significant main effects or interactions were revealed in the analysis of total shuttle responses performed during the PE and conditioning phases of the experiment (data not shown).
Hence, we confirm here that maternal PolyI:C exposure can lead to functional deficits in multiple neuropsychological domains in the grown offspring, [14] [15] [16] [17] [18] [19] and further reveal that the macrophagespecific overexpression of IL-10 in the maternal host can prevent the expression of the behavioral and cognitive deficits induced by prenatal immune activation. In the absence of a discrete inflammatory stimulus, however, enforced IL-10 overexpression by itself is linked to specific behavioral abnormalities in the form of deficient spatial exploration and associative learning.
Differential locomotor reaction to glutamatergic, but not dopaminergic, drug treatment in macIL-10tg and wt offspring after prenatal immune activation Prenatal immune challenge in rodents has previously been shown to lead to the post-pubertal emergence of functional imbalances in central dopaminergic and/or glutamatergic systems. [14] [15] [16] [17] [18] [19] We, therefore, also tested whether enhanced maternal IL-10 expression may be a critical determinant of this causal relationship. To this end, we compared the locomotor response to the indirect dopamine-receptor agonist, amphetamine (AMPH; 2.5 mg/kg, intraperitoneally), and the noncompetitive N-methyl D-aspartate (NMDA) receptor antagonist, dizocilpine (MK-801; 0.1 mg/kg, intraperitoneally) between prenatally vehicle-or PolyI:Ctreated macIL-10tg and wt offspring in the open field.
In agreement with the results obtained in the openfield exploration test (Figure 4b) , the four groups did not significantly differ in the distance traveled in the open-field arena after the administration of vehicle (saline) solution (Figure 7) . The systemic administration of AMPH resulted in a general increase in locomotor activity, which peaked at around 35 min post-injection (Figure 7a ). Prenatal PolyI:C exposure potentiated the animals' locomotor reaction to the drug particularly in the first half of the 60-min test session. This effect emerged independently of genotype, suggesting that prenatal PolyI:C-induced immune activation was similarly effective in enhancing the sensitivity to systemic AMPH in both macIL-10tg and wt offspring (Figure 7a) .
In contrast, the locomotor reaction to systemic MK-801 treatment was clearly different between offspring of PolyI:C-exposed wt and macIL-10tg mothers (Figure 7b ): Adult offspring born to PolyI:C-treated wt mice displayed a pronounced locomotor response to MK-801 that was notably higher than all other groups. The acute drug challenge only induced a modest increase of locomotor activity in prenatally vehicle-treated wt and macIL-10tg offspring, and it completely failed to induce a reliable hyperlocomotor response in offspring of PolyI:C-treated macIL-10tg mice (Figure 7b ).
Discussion
The present study provides the first piece of evidence for the hypothesis that the association between prenatal immune challenge and the emergence of behavioral dysfunctions in adulthood is critically dependent on the precise cytokine events taking place at the maternal-fetal interface. Enhanced levels of the anti-inflammatory cytokine IL-10 during prenatal development prevented the emergence of multiple behavioral and pharmacological abnormalities in the adult offspring after the prenatal exposure to proinflammatory treatment. In the absence of a discrete prenatal inflammatory event, however, enhanced levels of IL-10 in prenatal life was associated with specific behavioral abnormalities in adulthood. One important implication emerging from this contrast is that the development of normal adult brain functions may be, in part, under the critical influence of a balance between pro-and anti-inflammatory cytokines in prenatal life. According to this scheme, disturbance of this balance toward either cytokine class would therefore precipitate adult behavioral pathology, whereas the concomitant induction of both pro-and anti-inflammatory molecules in the fetal brain may diminish each other's long-term consequences on brain and behavioral functions. However, a shift toward increased pro-inflammatory cytokines can arguably be considered more pathologically effective compared to a shift toward the anti-inflammatory side. This is because a wide spectrum of behavioral and pharmacological abnormalities emerged after excessive pro-inflammatory molecules in the fetal brain, whereas the pathological phenotype was clearly restricted to certain behavioral dysfunctions after the shift toward enhanced fetal brain levels of IL-10 as such.
The direct comparison between the offspring's short-and long-term cytokine responses to maternal immune stimulation suggests that the behavioral dysfunctions induced by the enhanced expression of IL-10 as such are likely attributed primarily to increased IL-10 levels in prenatal and/or perinatal stages of development. This is because maternal immunological stimulation and/or macrophage-specific overexpression of IL-10 only altered cytokine contents in the offspring's fetal (Figure 2) but not adult brain (Table 1) . Most interestingly, adult brain IL-10 levels did not differ between wt and macIL-10tg mice, despite the marked increase of IL-10 protein in the peripheral immune system of the latter (Figure 1 ). These distinct effects of macrophage-specific IL-10 overexpression on fetal and adult IL-10 contents may be directly related to the maturation of the bloodbrain barrier (BBB) across different stages of prenatal and postnatal development. The fetal BBB in midgestation is immature and readily allows the entry of soluble molecules such as cytokines in the fetal brain compartments. 35 In contrast, the intact BBB in adulthood constitutes a highly efficient barrier against the penetration of molecules into the central nervous system, including IL-10. 36 This distinction thus lends further credence to the use of macIL-10tg animals as a Figure 7 Differential locomotor responses to systemic dizocilpine (MK-801), but not amphetamine (AMPH) administration in macIL-10tg and wt offspring after prenatal immune activation. No significant differences were detected between the four treatment groups in the locomotor reaction to saline (SAL) administration. Locomotor activity decreased over time, thereby leading to a clear habituation effect. (a) The administration of systemic AMPH (2.5 mg/kg, intraperitoneally) led to a general increase in locomotor activity, with offspring of PolyI:C-treated mothers displaying a potentiated locomotor response to the drug treatment independent of the genetic background. ANOVA of distance traveled in response to AMPH treatment yielded a significant prenatal treatment Â bins interaction term (F (11, 330) = 2.39; P < 0.01). Subsequent ANOVAs restricted to each of the 5-min bins further showed that prenatal PolyI:C exposure significantly enhanced the locomotor reaction to AMPH between 5 and 30 min post-injection in comparison with prenatal vehicle treatment (*P < 0.05). N(vehicle wt) = 9 (5#, 4~); N(PolyI:C wt) = 10 (5#, 5~); N(vehicle macIL-10tg) = 9 (5#, 4~); N(PolyI:C macIL-10tg) = 10 (5#, 5~). (b) Maternal PolyI:C exposure had a highly differential effect on the sensitivity to systemic MK-801 (0.1 mg/kg, intraperitoneally) in adult wt and macIL-10tg offspring. Whereas the drug treatment markedly enhanced locomotor activity in animals born to PolyI:C-treated wt mothers, a clear increase in locomotor activity after MK-801 treatment was absent in offspring of PolyI:C-treated macIL-10tg mice. On the other hand, the drug-induced enhancement of locomotor activity was highly comparable between prenatally vehicletreated wt and macIL-10tg offspring. ANOVA of distance traveled in response to MK-801 administration, yielded a significant genotype Â prenatal treatment interaction (F(1,30) = 6.88; P < 0.05). Subsequent Fisher's LSD post hoc comparisons between the four experimental groups confirmed the significant differences between wt PolyI:C-offspring and (i) wt vehicle-offspring (*P < 0.05), (ii) macIL-10tg PolyI:C-offspring (***P < 0.001) and (iii) macIL-10tg vehicle-offspring (**P < 0.01). N(vehicle wt) = 10 (5#, 5~); N(PolyI:C wt) = 9 (5#, 4~); N(vehicle macIL-10tg) = 10 (5#, 5~); N(PolyI:C macIL-10tg) = 9 (5#, 4~). All values are means7s.e.m. ANOVA, analysis of variance; IL-10, interleukin-10; LSD, least significant difference; PolyI:C, polyriboinosinic-polyribocytidilic acid; tg, transgenic; wt, wild type. means to investigate the interaction between cytokine-associated genetic and environmental factors in the prenatal infectious etiologies of adult behavioral dysfunctions within a neurodevelopmental perspective.
Consistent with the inhibitory effects of IL-10 on pro-inflammatory cytokine production, 22, 23, 37 macIL10tg animals displayed impaired peripheral IL-1b, IL-6 and TNF-a responses to the viral mimic PolyI:C in comparison with wt mice (Figure 1 ). This antiinflammatory effect is likely to be accounted for by the capacity of IL-10 to selectively suppress pro-inflammatory gene transcription in activated macrophages. 38 In addition, the macrophage-specific overexpression of IL-10 also abolished the fetal brain TNF-a response to maternal immunological stimulation. TNF-a is known to have potent neurodevelopmental effects by inhibiting neuronal cell survival 11 and cortical dendrite development 12 and synergistic interactions exist between TNF-a and other proinflammatory cytokines in these processes. 12, 39 Elevated fetal brain levels of TNF-a have also been implicated in the emergence of enhanced neuronal apoptosis in postnatal life. 17 Furthermore, increased maternal TNF-a levels during pregnancy have been directly associated with a higher incidence of postpubertal psychosis in the offspring. 40 Hence, there is considerable evidence linking abnormal maternal/ fetal TNF-a to a higher incidence of brain and behavioral pathology in the grown offspring. The efficacy of enhanced prenatal IL-10 levels to attenuate fetal brain TNF-a response to infection may therefore represent an important neuroimmunological mechanism underlying the observed normalization of multiple behavioral and pharmacological dysfunctions in adulthood. However, this does not exclude the possibility that alterations in other elements of the immune system, including other cytokine species, may also confer to the reduced vulnerability to prenatal inflammation-mediated brain and behavioral abnormalities in subjects overexpressing the antiinflammatory cytokine IL-10.
Interestingly, enhanced AMPH sensitivity ( Figure  7 ) and pulse-elicited startle reactivity ( Figure 5 ) emerged after prenatal inflammation regardless of the precise TNF-a contents in the fetal brain. This may suggest that excessive fetal brain levels of other inflammatory molecules, including IL-1b and IL-6, may additionally be involved in the precipitation of specific forms of adult behavioral disturbances. In fact, the precise pattern of adult behavioral and pharmacological abnormalities emerging after prenatal brain inflammation appears to be influenced by the specificity of pro-inflammatory cytokine events in the fetal brain. At the cellular levels, IL-1b has been shown to be the most capable in inducing the conversion of mesencephalic progenitor cells into a dopaminergic phenotype, 10 whereas IL-6 is highly efficacious in reducing the survival of fetal brain serotonin neurons. 11 Although the underlying molecular mechanisms have yet to be identified, this clearly illustrates that the effects of cytokines on early neurodevelopmental processes crucially depend on their specificity. 41 Here, we highlight that genetically determined differences in macrophage-derived IL-10 modulates cytokine specificity in a complex biological system such as the fetal brain, which in turn may critically shape the offspring's vulnerability to distinct forms of adult behavioral and pharmacological abnormalities after prenatal immune challenge or innate immune imbalances.
Although prenatal PolyI:C administration in mice does not fully mimic viral infection, it precipitates a variety of behavioral and pharmacological effects that are comparable with the long-term consequences of prenatal infection by human influenza virus in mice, including reduced PPI and spatial exploration, as well as increased sensitivity to acute NMDA receptor antagonism.
14 Furthermore, schizophrenia-like abnormalities have also been observed in rats prenatally exposed to the bacterial endotoxin LPS. 13 Given that exposure with PolyI:C, LPS and influenza virus are all capable of stimulating pro-inflammatory cytokine responses in the maternal host, 9, 26, 27 the findings from different prenatal infection and/or inflammation models in rodents readily support the hypothesis that enhanced expression of pro-inflammatory cytokines at the maternal-fetal interface may critically underlie the deleterious effects of prenatal infection and/or inflammation on normal brain and behavioral development. Here, we went on to show that this association might be specifically related to the balance between pro-and anti-inflammatory cytokine classes in prenatal life.
The environmental and genetic manipulations used in the present study were associated with marked cytokine reactions in both the maternal host as well as the fetal brain (Figures 1-3) . Hence, our experimental conditions may differ from the clinical manifestation of in utero exposure to bacterial or viral infections, which may be relatively subtle and may only have weaker effects on the developing fetus. Indeed, previous findings have indicated that some of the critical long-term effects of acute prenatal PolyI:C exposure in mice are dependent on the precise dose used. 14, 16 It follows that in utero infection and/or inflammation may only be capable of interfering with normal brain and behavioral development after fetal exposure to relatively high elevations in pro-inflammatory cytokine levels. In keeping with the suggestion that shifts of the balance between pro-and anti-inflammatory cytokine classes may be a critical determinant of the final impact on neurodevelopment following early life infection or innate immune imbalances, it will be of great relevance to compare the known dose-dependent effects of prenatal infection and/or inflammation on adult brain function against the efficacy of different doses of infectious/ inflammatory agents to affect the balance between pro-and anti-inflammatory cytokine classes in the fetal brain.
The multiple functional aberrations emerging in adult wt offspring after prenatal immune activation resemble some of the critical dysfunctions implicated in neuropsychiatric disorders of developmental origin, such as schizophrenia and autism. 16, 42 For example, deficits in sensorimotor gating, as evident in reduced PPI, is observed in a number of neuropsychiatric disorders, including schizophrenia, 29 schizotypal personality disorder, 43 autism 30 and obsessivecompulsive disorder. 44 On the other hand, impaired selective associative learning in the form of disrupted LI has been observed in a subset of schizophrenic patients, especially in those suffering acutely from positive symptoms. 33, 34 Moreover, both dopamine receptor agonists and NMDA receptor antagonists can produce psychosis-like states in healthy human subjects and exacerbate existing psychoses in schizophrenics. [45] [46] [47] [48] [49] Interestingly, increased response to acute AMPH treatment has been directly implicated in the positive symptoms of schizophrenia, 47 whereas acute pharmacological treatment with NMDA receptor antagonists may additionally induce memory impairments related to the cognitive symptoms of schizophrenia. 50 , 51 Prenatal immune activation by the inflammatory agent PolyI:C in mice thus precipitates a wide spectrum of adult behavioral and pharmacological abnormalities related especially to the symptom profiles in schizophrenia.
Importantly, in a recent cross-fostering study, we have demonstrated that significant brain and behavioral abnormalities emerged after prenatal PolyI:C exposure regardless of whether neonates were crossfostered to immune-challenged or control surrogate mothers. 18 Hence, it is unlikely that putative changes in maternal behavior resulting from immunological stress during pregnancy mediate the long-term behavioral effects of prenatal PolyI:C exposure. This further suggests that the apparent dissociation between the behavioral and pharmacological consequences of prenatal PolyI:C exposure in wt and macIL-10tg animals is most likely attributable to prenatal rather than postnatal effects. Furthermore, previous experiments in rats and mice have demonstrated that the effects of prenatal PolyI:C exposure on sensorimotor gating, selective associative learning and sensitivity to psychostimulant drugs are only apparent in adulthood, but not in pre-adolescence. 15, 18, 19 This suggests that the final emergence of long-term behavioral and pharmacological dysfunctions following prenatal immune challenge are dependent on post-pubertal maturational mechanisms, an effect that is consistent with the characteristic maturational delay of schizophrenia. 2 Hence, prenatal immune challenge by PolyI:C exposure in rodents may provide a neurodevelopmental model that mimics the temporal course, as well as some critical behavioral and pharmacological dysfunctions in schizophrenia and related disorders.
Since enhanced levels of IL-10 at the maternal-fetal interface largely prevented the prenatal PolyI:Cinduced emergence of adult behavioral and pharmacological dysfunctions in macIL-10tg animals, our data do not support the hypothesis that genetically determined excess of IL-10 linked to Il10 promoter polymorphisms could interact with prenatal inflammation to increase the risk for schizophrenia-related pathology in adulthood. 52, 53 Instead, our data show that excessive prenatal IL-10 levels decrease the risk for adult behavioral pathology after in utero immune challenge, at least when inflammation takes place in early-to-mid-pregnancy. However, in as much as we have demonstrated significant behavioral dysfunctions in prenatally vehicle-treated macIL-10tg offspring, our data readily support the hypothesis that enhanced levels of IL-10 in prenatal life as such, that is in the absence of a discrete inflammatory event, may significantly interfere with normal brain development and lead to behavioral dysfunctions in adulthood. 52, 53 The potential of IL-10 to modulate early brain development certainly remains to be further explored. The fact that IL-10 is constitutively expressed during fetal brain development in both mice 17 and humans 54 readily suggests an essential role for this molecule in early neurodevelopmental processes. Further studies are therefore clearly warranted to explore more specifically the unique roles of IL-10 in brain development, in addition to its interaction with the various neurodevelopmental effects attributed to proinflammatory cytokines. The present study highlighted that normal brain functions in adult life may not only be affected by excess pro-inflammatory molecules in prenatal development, but significant long-term behavioral and cognitive dysfunctions may also develop as a consequence of the disruption of the balance between pro-and anti-inflammatory cytokine signaling. Hence, relative shifts between distinct cytokine classes have to be taken into consideration to identify the ultimate neurodevelopmental impact of these molecules in prenatal infectious conditions and innate immune imbalances.
